Jennifer Lynne Miller MD
Professor, Pediatrics, University of Florida College of Medicine
Join to View Full Profile
1600 SW Archer RdGainesville, FL 32610
Phone+1 352-265-7337
Fax+1 352-294-8097
Dr. Miller is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of FloridaFellowship, Pediatric Endocrinology, 2001 - 2004- University of FloridaResidency, Pediatrics, 1998 - 2001
- University of Florida College of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2001 - 2028
NC State Medical License 2020 - 2022
OK State Medical License 2020 - 2021
AL State Medical License 2020 - 2020
American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome Start of enrollment: 2013 Jun 01
- Hypoglycemia in Prader-Willi Syndrome Start of enrollment: 2013 Jul 01
- Oxytocin Trial in Prader-Willi Syndrome Start of enrollment: 2015 Mar 01
Publications & Presentations
PubMed
- 2 citationsDiazoxide Choline Extended-release Tablets in Prader-Willi Syndrome: A Randomized, Double-blind, Withdrawal Period Study.Jennifer L Miller, Nicola Bridges, Eric I Felner, Parisa Salehi, Jack A Yanovski
The Journal of Clinical Endocrinology and Metabolism. 2026-05-19 - An open-label pilot study of psilocybin-assisted therapy for binge eating disorder.Jesse Dallery, Jennifer L Miller, Jeff Boissoneault, Lauren Harvey, Lindsey Ives
Journal of Eating Disorders. 2026-01-03 - 2 citationsHyperphagia in rare melanocortin-4 receptor pathway diseases: therapeutic options and assessing treatment response.Jesús Argente, Karine Clément, Jessica Duis, I Sadaf Farooqi, Peter Kühnen
Reviews in Endocrine & Metabolic Disorders. 2025-12-01
Press Mentions
Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6THNovember 6th, 2025
First Drug Approved for Hyperphagia in Prader-Willi SyndromeMarch 28th, 2025
Pivotal Study Shows Benefit of Oral Therapy for Patients with Prader-Willi SyndromeJanuary 13th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
